Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | NUE | CRH |
|---|---|---|
| Price | $249.53 | $83.94 |
| Change today | ▲ 1.03% | ▼ 1.51% |
| Market cap | $56.61B | $55.84B |
| Return, 3 months | +4.0% | -24.8% |
| Return, year to date | +53.9% | -32.0% |
| Return, 1 year | +85.4% | -24.4% |
| P/E (TTM) | 19.9 | 14.8 |
| P/B | 2.6 | 2.3 |
| P/E percentile vs own 5y | 76th | 35th |
| Dividend yield | 0.89% | 1.81% |
| Revenue growth (YoY, latest qtr) | +23.0% | +5.6% |
| Net profit growth (YoY) | +81.3% | +13.4% |
| Gross margin | 15.5% | 36.2% |
| Operating margin | 11.5% | 14.1% |
| Net margin | 8.0% | 9.9% |
| Return on equity | 13.5% | 16.4% |
| Analyst target vs. price | +14.9% | +62.4% |
| Analyst buy share | 80% | 100% |
| RSI (14) | 44 | 34 |
| 30-day volatility | 36.9% | 27.1% |
| Max drawdown, 1 year | -18.4% | -34.1% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.